STOCK TITAN

Pulse Biosciences to Participate in the Jefferies Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Pulse Biosciences, Inc. (Nasdaq: PLSE) has announced its participation in the Jefferies Virtual Healthcare Conference, scheduled for June 2, 2021, at 12:30pm PT. The company is known for its innovative CellFX System powered by Nano-Pulse Stimulation™ (NPS™) technology, designed to treat various dermatologic conditions effectively. The CellFX System represents a significant advancement in bioelectric medicine, offering a non-thermal method that targets specific cells while preserving surrounding tissues. Interested viewers can access the webcast through the company’s website.

Positive
  • None.
Negative
  • None.

Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company introducing the CellFX System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced plans to participate in the Jefferies Virtual Healthcare Conference.

Management is scheduled to present at 12:30pm PT on Wednesday, June 2, 2021. Interested parties may access the live and recorded webcast on the “Investors” section of the Company’s website at www.pulsebiosciences.com.

About Pulse Biosciences®

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The company’s proprietary Nano-Pulse Stimulation (NPS™) technology delivers nano-second pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. The CellFX® System is the first commercial product to harness the distinctive advantages of NPS technology to treat a variety of applications for which an optimal solution remains unfulfilled. The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model.

To stay informed about the CellFX System, please visit CellFX.com and sign-up for updates.

Pulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.

FAQ

When is Pulse Biosciences presenting at the Jefferies Virtual Healthcare Conference?

Pulse Biosciences will present on June 2, 2021, at 12:30pm PT.

What technology does Pulse Biosciences' CellFX System use?

The CellFX System utilizes Nano-Pulse Stimulation™ (NPS™) technology to treat dermatologic conditions.

How can I watch Pulse Biosciences' presentation?

The live and recorded webcast can be accessed on the 'Investors' section of Pulse Biosciences' website.

What are the benefits of Nano-Pulse Stimulation technology?

NPS technology delivers nano-second pulses of energy that selectively clear cells while sparing adjacent non-cellular tissue.

What is the main focus of Pulse Biosciences' CellFX System?

The CellFX System is designed to improve dermatologic outcomes for a variety of skin conditions.

Pulse Biosciences, Inc

NASDAQ:PLSE

PLSE Rankings

PLSE Latest News

PLSE Stock Data

1.00B
17.26M
71.93%
9.32%
4.12%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
HAYWARD